Bone Biologics Corporation (BBLG)
Bone Biologics has a market cap or net worth of $29.29 million. The enterprise value is $42.06 million.
|Ex-Dividend Date||Oct 13, 2021|
Bone Biologics has 10.35 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||0.00%|
|Owned by Insiders (%)||70.04%|
|Owned by Institutions (%)||n/a|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 0.00, with a Debt / Equity ratio of n/a.
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-5,896.00%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.89M|
|Effective Tax Rate||n/a|
Stock Price Statistics
. The beta is -0.21, so Bone Biologics's price volatility has been lower than the market average.
|52-Week Price Change||n/a|
|50-Day Moving Average||3.62|
|200-Day Moving Average||3.96|
|Average Volume (30 Days)||1,715,951|
Short Selling Information
|Short % of Shares Out||0.35%|
|Short % of Float||1.16%|
|Short Ratio (days to cover)||0.16|
|Earnings Per Share (EPS)||-$0.15|
The company has $3,374 in cash and $12.77 million in debt, giving a net cash position of -$12.76 million or -$1.23 per share.
|Cash & Cash Equivalents||3,374|
|Net Cash Per Share||-$1.23|
|Book Value Per Share||-1.46|
|Operating Cash Flow||-1.17M|
|Free Cash Flow||-1.17M|
|FCF Per Share||n/a|
Dividends & Yields
Bone Biologics does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on October 13, 2021. It was a reverse split with a ratio of 1:2.
|Last Split Date||Oct 13, 2021|